To the editor,
We read with a great interest the article ‘‘Increased mean platelet volume (MPV) and mean platelet volume/platelet count (MPV/P) ratio in Korean patients with deep vein thrombosis (DVT)” written by Han and coworkers Citation[1]. They aimed to compare the MPV and MPV/P ratio between DVT and control subjects. They demonstrated that MPV was higher in DVT patients compared to controls. The DVT patients also had a higher MPV/P ratio compared to the control group. MPV was conversely correlated with the platelet count in DVT patients. They suggested that the MPV and MPV/P ratio may be considered meaningful laboratory markers for the risk of DVT. The study is successful in design and documentation.
DVT is a common disease found worldwide. It presents symptoms ranging from asymptomatic to fatal pulmonary embolism. So, prevention and early diagnosis of DVT are very important. The presence of DVT was closely associated with increased platelet activation Citation[2]. Blood stasis, vascular endothelial injury, and hypercoagulable conditions are well-known risk factors of DVT. It has also been related to obesity, smoking, previous surgical history, trauma, cancer, immobilization and another platelet dysfunctions Citation[3]. In contrast to the present study, the authors demonstrated downregulation of platelet activation after long-term immobilization in the previous study Citation[4]. For this reason, we think that because platelet function can affect various factors, further studies should consider these conditions.
A complete blood count is a routine, easy, and cheap examination technique that gives information about the patient's formed blood contents; the red and white cells, platelets, the counts and dimensions of subgroups of cells, and parameters like the distribution widths, mean platelet volume. MPV is one of the most widely used laboratory markers to be related to the platelet function based on the inflammatory condition Citation[5], Citation[6]. MPV also indicates the function of platelet, which is central to processes that are involved in coronary heart disease pathophysiology and endothelial dysfunction Citation[7], Citation[8]. Platelet parameters can be affected by coronary risk factors including age, obesity, smoking, diabetes mellitus, hypertension, hyperlipidemia metabolic syndrome Citation[6]. Another study demonstrated that MPV can be predicted in patients with stroke Citation[9]. Some other recent studies have presented that elevated MPV is linked with peripheral artery disease and stroke, all of which are related to atherosclerosis on the basis of inflammation Citation[5]. Previous studies demonstrated an association between the long-term mortality after non-ST-segment elevation myocardial infarction and the peripheral blood platelet indices including the MPV, platelet count, and the MPV/P ratio Citation[10]. It can also be affected by thyroid and rheumatic diseases Citation[11], Citation[12], malignancy and medications such as anticoagulant therapy, statins. So, if the authors had mentioned these factors, it might be useful.
MPV is as an important marker of inflammation. Previous study has shown that MPV showed significant differences in patients with hepatic diseases Citation[13]. On the other hand, MPV value was higher in chronic obstructive pulmonary disease patients compare with those of the control group Citation[14], Citation[15]. Therefore, if the authors gave information about hepatic function tests and respiratory condition, the results of the present study may be different and stronger.
Additionally, it would be better if the authors defined how much time they specified on measuring MPV levels, because the delaying blood sampling can cause abnormal results in MPV measurements.
Finally, MPV may be affected by many factors, the routine clinical usage of these parameters may not be reasonable yet. MPV itself alone without other overt inflammatory markers may not give information to clinicians about the chronic endothelial inflammatory condition of the patient at the first look. So, we think that it should be evaluated together with other inflammatory markers. We believe that these findings will guide further studies about MPV as a surrogate marker of endothelial dysfunction and inflammation in patients with DVT. We thank the authors for their contribution.
Declaration of interest
The author reports no conflict of interest. The author alone is responsible for the content and writing of the paper.
References
- Han JS, Park TS, Cho SY, Joh JH, Ahn HJ. Increased mean platelet volume and mean platelet volume/platelet count ratio in Korean patients with deep vein thrombosis. Platelets 2012, Dec 7 [Epub ahead of print]
- Gulcan M, Varol E, Etli M, Aksoy F, Kayan M. Mean platelet volume is increased in patients with deep vein thrombosis. Clin Appl Thromb Hemost 2012;18(4):427–430
- Flores-Nascimento MC, Beltrame MP, De Paula EV, Montalvão SL, Pereira FG, Orsi FL, Lorand-Metze I, Annichino-Bizzacchi JM. Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden. Platelets 2009;20(6):367–375
- Arinell K, Fröbert O, Blanc S, Larsson A, Christensen K. Downregulation of platelet activation markers during long-term immobilization. Platelets 2012, Aug 29 [Epub ahead of print]
- Wang R-T, Li Y, Zhu X-Y, Zhang Y-N. Increased mean platelet volume is associated with arterial stiffness. Platelets 2011;22: 447–451
- Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation?. Curr Pharm Des 2011;17: 47–58
- Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20: 23–28
- Demirkol S, Balta S, Unlu M, Yuksel UC, Celik T, Arslan Z, et al. Evaluation of the mean platelet volume in patients with cardiac syndrome X. Clinics (São Paulo, Brazil) 2012;67(9):1019–1022
- Cho SY, Jeon Y La, Choi SK, Suh J-T, Lee HJ, Park TS. Mean platelet volume in Korean patients with acute ischemic stroke: A gender difference. Platelets 2013;24(1):75–76
- Azab B, Torbey E, Singh J, Akerman M, Khoueiry G, McGinn JT, Widmann WD, Lafferty J. Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets 2011;22(8):557–566
- Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: Mean platelet volume reflects disease activity. Platelets 2010;21(2):122–125
- Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-α therapy. Rheumatol Int 2010;30(8):1125–1129
- Cho SY, Lee A, Lee HJ, Suh J-T, Park TS. Mean platelet volume in Korean patients with hepatic diseases. Platelets 2012;23(8):648–649
- Cho SY, Suh JS, Cho BS, Lee WI, Lee HJ, Suh JT, Park TS. Mean platelet volume in pediatric chronic kidney diseases. Platelets. 2013;24(2):164–5
- Biljak VR, Pancirov D, Cepelak I, Popović-Grle S, Stjepanović G, Grubišić TŽ. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets 2011;22(6):466–470